[
1. Baulieu EE, Robel P. Neurosteroids. A new brain function? J. Steoid Biochem. Mol. Biol. 1990; 37(3):S395-403.10.1016/0960-0760(90)90490-C
]Search in Google Scholar
[
2. Corpéchot C, Synguelakis M, Talha S, Axelson M, Sjövall J, Vihko R et al. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 1983; 270(1):S119-25.10.1016/0006-8993(83)90797-7
]Search in Google Scholar
[
3. Corpéchot C, Robel P, Axelson M, Sjövall J, Baulieu EE. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc. Natn. Acad. Sci U.S.A. 1981;78(8):S4704-7.10.1073/pnas.78.8.4704
]Search in Google Scholar
[
4. Selye H. Anesthetic Effect of Steroid Hormones. Proc Soc Exp Biol Med. 1941; 46(1):S116–21.10.3181/00379727-46-11907
]Search in Google Scholar
[
5. Harrison NL, Simmonds MA. Modulation of the GABA receptor complex by a steroid anaesthetic. Brain Res. 1984;232(2):S 287-92.10.1016/0006-8993(84)90299-3
]Search in Google Scholar
[
6. Harrison NL, Vicini S, Barker JL. A steroid anesthetic prolongs inhibitory postsynaptic currents in cultured rat hippocampal neurons. J neurosci. 1987;7(2):S604-9.10.1523/JNEUROSCI.07-02-00604.1987
]Search in Google Scholar
[
7. Joksimovic SL, Covey Douglas F, Jevtovic-Todorovic V, Todorovic Slobodan M. Neurosteroids in Pain Management: A New Perspective on an Old Player. Front Pharmacol. 2018;9:S1127.10.3389/fphar.2018.01127617605130333753
]Search in Google Scholar
[
8. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology. 1986;36(12):S1607.10.1212/WNL.36.12.1607
]Search in Google Scholar
[
9. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 1995;45(9):S1660-2.10.1212/WNL.45.9.1660
]Search in Google Scholar
[
10. Joshi S, Kapur J. Neurosteroid regulation of GABA-A receptors: A role in catamenial epilepsy. Brain Res. 2019;1703:S31-40.10.1016/j.brainres.2018.02.031610744629481795
]Search in Google Scholar
[
11. Monaghan EP, McAuley JW, Data JL. Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy. Expert Opin Investig Drugs. 1999;8:S1663-71.10.1517/13543784.8.10.1663
]Search in Google Scholar
[
12. Reddy DS, Rogawski MA. Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model. Epilepsy Res. 2010;89(2-3):S254-260.10.1016/j.eplepsyres.2010.01.009
]Search in Google Scholar
[
13. Uzunov DP, Cooper BT, Costa E, Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc Natl Acad Sci USA. 1996;93(22):S12599-604.10.1073/pnas.93.22.12599
]Search in Google Scholar
[
14. Khisti RT, Chopde CT. Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3α-hydroxy-5α-pregnan-20-one in mice. Brain Res. 2000;865(2):291-300.
]Search in Google Scholar
[
15. Eser D, Baghai TC, Schule C, Nothdurfter C, Rupprecht R. Neuroactive Steroids as Endogenous Modulators of Anxiety. Curr. Pharm. Des. 2008; 14(33):S3525-33.10.2174/138161208786848838
]Search in Google Scholar
[
16. Ičíková M, Dibbelt L, Hiill M, Hampl R, Stárka L. Allopregnenolone in women with premenstrual syndrom. Horm. Metab. Res. 1998;30(4):S227 – 9.10.1055/s-2007-978871
]Search in Google Scholar
[
17. Ratner MH, Kumaresan V, Farb DH. Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders. Front Endocrinol. 2019;10:S169.10.3389/fendo.2019.00169
]Search in Google Scholar
[
18. Rahmani B, Ghasemi R, Dargahi L, Ahmadiani A, Haeri A. Neurosteroids: potential underpinning roles in maintaining homeostasis. Gen Comp Endocrinol. 2016; 225:S242-50.10.1016/j.ygcen.2015.09.030
]Search in Google Scholar
[
19. Melcangi RC, Giatti S, Pesaresi M, Carabrese D, Mitro N, Caruso D et al. Role of Neuroactive Steroids in the Peripheral Nervous System. Front Endocrinol. 2011;2:S104.10.3389/fendo.2011.00104
]Search in Google Scholar
[
20. Melcangi RC, Garcia-Segura LM, Mensah-Nyagan, AG. Neuroactive steroids: State of the art and new perspectives. Cell. Mol. Life Sci. 2008;65(5):S777-97.10.1007/s00018-007-7403-5
]Search in Google Scholar
[
21. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol. Metab. 2002;13(1): S35-43.10.1016/S1043-2760(01)00503-3
]Search in Google Scholar
[
22. Baulieu EE, Robel P, Schumacher M. Neurosteroids: Beginning of the story. Int. Rev. Neurobiol. 2001;46:S1-32.10.1016/S0074-7742(01)46057-0
]Search in Google Scholar
[
23. Liu J, Rone MB, Papadopoulos V. Protein-Protein Interactions Mediate Mitochondrial Cholesterol Transport and Steroid Biosynthesis. J Biol Chem. 2006;281(50):S38879-93.10.1074/jbc.M60882020017050526
]Search in Google Scholar
[
24. Caleb BK, Billheimer TJ, Summers SA, Stayrook SE, Lewis M, Strauss FJ. Steroidogenic Acute Regulatory Protein (StAR) Is A Sterol Transfer Protein. J Biol Chem. 1989;273(41):S26285-88.10.1074/jbc.273.41.262859756854
]Search in Google Scholar
[
25. Bose M, Whittal RM, Miller WL, Bose HS. Steroidogenic Activity of StAR Requires Contact with Mitochondrial VDAC1 and Phosphate Carrier Protein, J Biol Chem. 2008;283(14):S8837-45.10.1074/jbc.M709221200227637518250166
]Search in Google Scholar
[
26. Selvaraj V, Stocco DM. The changing landscape in translocator protein (TSPO) function. Trends Endocrinol. Metab. 2015;26(7):S341-8.10.1016/j.tem.2015.02.007717165225801473
]Search in Google Scholar
[
27. Selvaraj V, Stocco DM, Tu LN. Minireview: Translocator Protein (TSPO) and Steroidogenesis: A Reappraisal. Mol. Cell. Endocrinol. 2015; 29(4):S490-501.10.1210/me.2015-1033439928025730708
]Search in Google Scholar
[
28. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience. 2006; 138(3):S749-56.10.1016/j.neuroscience.2005.05.06316338086
]Search in Google Scholar
[
29. Reddy DS. Neurosteroids: endogenous role in the human brain and therapeutic potentials. Prog Brain Res. 2010;186:S113-37.10.1016/B978-0-444-53630-3.00008-7313902921094889
]Search in Google Scholar
[
30. Chung BC, Matteson KJ, Voutilainen R, Mohandas TK, Miller WL. Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta. Proc Natl Acad Sci U S A. 1986;83(23):S8962-66.10.1073/pnas.83.23.89623870543024157
]Search in Google Scholar
[
31. Yasushi H, Suguru M. Neurosteroids in Adult Hippocampus of Male and Female Rodents: Biosynthesis and Actions of Sex Steroids. Front Endocrinol. 2018;9:S183.10.3389/fendo.2018.00183592596229740398
]Search in Google Scholar
[
32. Agís-Balboa RC, Pinna G, Zhubi A, Maloku E, Veldic M, Costa E et al. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA. 2006;103(39):S14602-7.10.1073/pnas.0606544103
]Search in Google Scholar
[
33. Mueller JW, Gilligan LC, Idkowiak J, Arlt W, Foster PA. The Regulation of Steroid Action by Sulfation and Desulfation. Endocr Rev. 2015;36(5):S526-63.10.1210/er.2015-1036
]Search in Google Scholar
[
34. Hobkirk R. Steroid sulfation. Trends Endocrinol. Metab. 1993; 4(2):S 69-74.10.1016/S1043-2760(05)80018-9
]Search in Google Scholar
[
35. Do Rego JL, Seong JY, Burel D et al. Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides. Front Endocrinol (Lausanne). 2012; 3:S4.10.3389/fendo.2012.00004
]Search in Google Scholar
[
36. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and function of these novel neuromodulators. Front. Neuroendocrinol. 2000;21(1):S1-56.10.1006/frne.1999.0188
]Search in Google Scholar
[
37. Rupprecht R, Reul JM, Trapp T et al. Progesterone receptor-mediated effects of neuroactive steroids. Neuron. 1993;11(3):S523-30.10.1016/0896-6273(93)90156-L
]Search in Google Scholar
[
38. Joëls M. Steroid Hormones and Excitability in the Mammalian Brain. Front. Neuroendocrinol. 1997;18(1):2-48.
]Search in Google Scholar
[
39. Reddy DS, Apanites LA. Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice. Brain Res. 2005;1033(1):S96-101.10.1016/j.brainres.2004.11.02615680344
]Search in Google Scholar
[
40. Reddy DS, Castaneda DC, O’Malley BW, Rogawski MA. Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice. J Pharmacol Exp Ther. 2004;310(1):S230-9.10.1124/jpet.104.06526814982969
]Search in Google Scholar
[
41. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science. 1986;232(4753):S1004-7.10.1126/science.24227582422758
]Search in Google Scholar
[
42. Lambert JJ, Belelli D, Hill-Venning C. et al. Neurosteroid modulation of native and recombinant GABA-A receptors. Cell Mol Neurobiol. 1996;16(2):S155-74.10.1007/BF020881748743967
]Search in Google Scholar
[
43. Wu FS, Gibbs TT, Farb DH. Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol.1991;40(3):S333-6.
]Search in Google Scholar
[
44. Sieghart W. Structure, pharmacology and function of GABAA receptor subtypes. Adv. Pharmacol. 2006;54:S231-63.10.1016/S1054-3589(06)54010-4
]Search in Google Scholar
[
45. Porcu P, Barron AM, Frye CA, Walf AA, Yang SY, He XY. Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research. J Neuroendocrinol. 2016;28(2):S1-19.10.1111/jne.12351
]Search in Google Scholar
[
46. Nakamura Y, Darnieder LM, Deeb TZ et al. Regulation of GABAA Rs by Phosphorylation. Adv Pharmacol. 2015;72:S97-146.10.1016/bs.apha.2014.11.008
]Search in Google Scholar
[
47. Majewska MD. Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance. Prog. Neurobiol. 1992;38(4):S379-94.10.1016/0301-0082(92)90025-A
]Search in Google Scholar
[
48. Reddy DS. Pharmacology of endogenous neuroactive steroids, Crit Rev Neurobiol. 2003;15:S197-234.10.1615/CritRevNeurobiol.v15.i34.20
]Search in Google Scholar
[
49. Morrow AL. Recent developments in the significance and therapeutic relevance of neuroactive steroids - Introduction to the special issue. Pharmacol Ther. 2007;116(1):S1-6.10.1016/j.pharmthera.2007.04.003204781617531324
]Search in Google Scholar
[
50. Hénin J, Salari R, Murlidaran S et al. A predicted binding site for cholesterol on the GABAA receptor. Biophys. J. 2014;106(9):S1938-49.10.1016/j.bpj.2014.03.024401728524806926
]Search in Google Scholar
[
51. Paul SM, Doherty JJ, Robichaud AJ et al. The Major Brain Cholesterol Metabolite 24(S)-Hydroxycholesterol Is a Potent Allosteric Modulator of N-Methyl-D-Aspartate Receptors. J Neurosci. 2013; 33(44):S17290–300.10.1523/JNEUROSCI.2619-13.2013381250224174662
]Search in Google Scholar
[
52. Li F, Tsien JZ. Memory and the NMDA receptors. N Engl J Med. 2009; 361(3):S302-3.10.1056/NEJMcibr0902052370375819605837
]Search in Google Scholar
[
53. Schumacher M, Robel P. Baulieu EE. Development and regeneration of the nervous system: a role for neurosteroids. Dev Neurosci. 1996;18(1-2):S 6-21.10.1159/000315793
]Search in Google Scholar
[
54. Lambert JJ, Cooper MA, Simmons RDJ, Weir CJ, Belelli D. Neurosteroids: Endogenous allosteric modulators of GABAA receptors. Psychoneuroendocrinology. 2009;34(1):S48-58.10.1016/j.psyneuen.2009.08.009
]Search in Google Scholar
[
55. Mayo W, Dellu F, Robel P, Cherkaoui J, Le Moal M, Baulieu EE et al. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 1993;607(1-2):S324-8.10.1016/0006-8993(93)91524-V
]Search in Google Scholar
[
56. Wang JM, Singh C, Liu L, Irwin RW, Chen S, Chung EJ et al. Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 2010;107(24):S11145.10.1073/pnas.1006236107
]Search in Google Scholar
[
57. Bengtsson SK, Johansson M, Bäckström T, Wang M. Chronic allopregnanolone treatment accelerates Alzheimer’s disease development in βPP(Swe)PSEN1(ΔE9) mice. J Alzheimers Dis. 2012;31(1):S71-84.10.3233/JAD-2012-120268
]Search in Google Scholar
[
58. Bengtsson SK, Johansson M, Bäckström T, Nitsch RM, Wang M. Brief but Chronic Increase in Allopregnanolone Cause Accelerated AD Pathology Differently in Two Mouse Models. Curr Alzheimer Res. 2013;10(1):S38-47.10.2174/156720513804871363
]Search in Google Scholar
[
59. Ladurelle N, Eychenne B, Denton D, Blair-West J, Schumacher M, Robel P et al. Prolonged intracerebroventricular infusion of neurosteroids affects cognitive performances in the mouse. Brain Res. 2000;858(2):S371-9.10.1016/S0006-8993(00)01953-3
]Search in Google Scholar
[
60. Darnaudéry M, Koehl M, Piazza PV, Le Moal M, Mayo W. Pregnenolone sulfate increases hippocampal acetylcholine release and spatial recognition. Brain Res. 2000;852(1):S173-9.10.1016/S0006-8993(99)01964-2
]Search in Google Scholar
[
61. Hillen T, Lun A, Reischies FM, Borchelt M, Steinhagen-Thiessen E, Schaub RT. DHEA-S plasma levels and incidence of Alzheimer’s disease. Biol. Psychiatry. 2000;47(2):S161-3.10.1016/S0006-3223(99)00217-6
]Search in Google Scholar
[
62. Maurice T, Su TP. Privat A. Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism. Neuroscience. 1998;83(2):S413-28.10.1016/S0306-4522(97)00405-3
]Search in Google Scholar
[
63. Riedel G, Davies SN. Cannabinoid Function in Learning, Memory and Plasticity. Cannabinoids. Handb Exp Pharmacol. 2005;168:S445-77.10.1007/3-540-26573-2_1516596784
]Search in Google Scholar
[
64. Wang W, Jia Y, Pham DT, Palmer LC, Jung KM, Cox CD et al. Atypical Endocannabinoid Signaling Initiates a New Form of Memory-Related Plasticity at a Cortical Input to Hippocampus. Cereb Cortex. 2018;28(7):S2253-66.10.1093/cercor/bhx126
]Search in Google Scholar
[
65. Gaspar PA, Bustamante ML, Silva H, Aboitiz F. Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications. J Neurochem. 2009;111(4):S891-900.10.1111/j.1471-4159.2009.06325.x
]Search in Google Scholar
[
66. Labrie V, Roder JC. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neurosci Biobehav Rev. 2010;34(3):S351-72.10.1016/j.neubiorev.2009.08.002
]Search in Google Scholar
[
67. Marx CE, Keefe RS, Buchanan RW et al. Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia. Neuropsychopharmacology. 2009;34(8):S1885-903.10.1038/npp.2009.26
]Search in Google Scholar
[
68. Riordan AJ, Schaler AW, Fried J, Paine TA, Thornton JE. Estradiol and luteinizing hormone regulate recognition memory following subchronic phencyclidine: Evidence for hippocampal GABA action. Psychoneuroendocrinology. 2018; 91:S86-9410.1016/j.psyneuen.2018.02.024
]Search in Google Scholar
[
69. Li PK, Rhodes ME, Burke AM et al. Memory enhancement mediated by the steroid sulfatase inhibitor (p-O-sulfamoyl)-N-tetradecanoyl tyramine. Life Sci. 1997;60(3):S 45-51.10.1016/S0024-3205(96)00621-2
]Search in Google Scholar
[
70. Wang C, Marx CE, Morrow AL, Wilson WA, Moore SD. Neurosteroid modulation of GABAergic neurotransmission in the central amygdala: a role for NMDA receptors. Neurosci Lett. 2007;415(2):S118-23.10.1016/j.neulet.2007.01.004189263117275189
]Search in Google Scholar
[
71. Ströhle A, Romeo E, Michele F et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results. Arch Gen Psychiatry. 2003;60(2):S161-8.10.1001/archpsyc.60.2.16112578433
]Search in Google Scholar